NovoCure Ltd (NAS:NVCR)
$ 23.15 0.84 (3.77%) Market Cap: 2.49 Bil Enterprise Value: 2.13 Bil PE Ratio: 0 PB Ratio: 6.68 GF Score: 60/100

Q2 2019 Novocure Ltd Earnings Call Transcript

Jul 25, 2019 / 12:00PM GMT
Release Date Price: $77.08 (+8.58%)
Operator

Good day, ladies and gentlemen, and welcome to Novocure's Second Quarter 2019 Performance Conference Call. (Operator Instructions) As a reminder, this conference call may be recorded.

I would now like to introduce your host for today's conference, Ms. Ashley Cordova, Senior Vice President of Finance and Investor Relations. Ma'am, you may begin.

Ashley Cordova
NovoCure Limited - VP of Finance & IR

Good morning, everyone, and thank you for joining us to review Novocure's second quarter 2019 performance. I am joined today by our Executive Chairman, Bill Doyle; our CEO, Asaf Danziger; our CFO, Wilco Groenhuysen; and our Chief Medical Officer, Ely Benaim. The slides presented today can be viewed on our website, www.novocure.com, by clicking on the link for second quarter 2019 financial results located in the Events section on our Investor Relations page.

Before we start, I would like to remind you that our discussions during this conference call will include forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot